The National Academies of Medicine (NAM) addresses the treatment gap in medically-assisted treatment for opioid use disorder (OUD), and presents strategies for increasing access to medicines such as buprenorphine and methadone.
The National Academies of Medicine (NAM) addresses the treatment gap in medically-assisted treatment for opioid use disorder (OUD), and presents strategies for increasing access to medicines such as buprenorphine and methadone.